As displayed in Figure 4A, the frequency of ADRA2C alteration (2.2%) was the highest in adrenocortical carcinoma with 'mutation' as the primary type, and all adrenocortical carcinoma patients had ADRA2C mutation. This evidence concerns the gene ADRA2C and adrenal cortex carcinoma.